首页> 美国卫生研究院文献>Physiological Reports >Macrophage migration inhibitory factor mediates protease‐activated receptor 4‐induced bladder pain through urothelial high mobility group box 1
【2h】

Macrophage migration inhibitory factor mediates protease‐activated receptor 4‐induced bladder pain through urothelial high mobility group box 1

机译:巨噬细胞迁移抑制因子通过尿路上皮高迁移率介导蛋白酶激活受体4引起的膀胱疼痛1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Macrophage migration inhibitory factor (MIF) mediates pain although the mechanisms are not well understood. Urothelial activation of protease activated receptor 4 (PAR4) results in urothelial MIF release, urothelial high mobility group box 1 (HMGB1) release and bladder pain in mice without bladder inflammation. All three effects are prevented by MIF inhibition while intravesical disulfide HMGB1 alone can induce bladder pain. This study utilizes genetic MIF deletion to determine whether MIF mediates PAR4‐induced bladder pain and is upstream of HMGB1‐induced bladder pain. Wild type (C57/BL6) and MIF knockout (KO) mice were treated with intravesical PAR4 activating peptide or disulfide HMGB1 and tested for abdominal mechanical hypersensitivity at baseline (before treatment) and 24 h after injection. Micturition parameters and bladder histology were examined after behavioral test. Real‐time PCR and western blotting measured style="fixed-case">HMGB1 m style="fixed-case">RNA and protein levels in the bladders of naïve wild type and style="fixed-case">MIF KO mice, while immunofluorescence measured style="fixed-case">HMGB1 protein levels in the urothelium of both strains. Intravesical style="fixed-case">PAR4 activation resulted in abdominal mechanical hypersensitivity in wild‐type mice but not style="fixed-case">MIF KO mice. Intravesical disulfide style="fixed-case">HMGB1 induced abdominal mechanical hypersensitivity in both strains. Neither treatment resulted in significant changes in micturition or bladder histology in either strain. style="fixed-case">HMGB1 m style="fixed-case">RNA and protein levels were higher in style="fixed-case">MIF KO mouse bladders and the urothelium of style="fixed-case">MIF KO bladder had greater immunostaining than the wild‐type strain. style="fixed-case">MIF is a pivotal molecule mediating style="fixed-case">PAR4‐induced bladder pain and regulating urothelial style="fixed-case">HMGB1 production and release to elicit bladder pain.
机译:巨噬细胞迁移抑制因子(MIF)介导疼痛,尽管其机理尚不清楚。尿激酶激活的蛋白酶激活受体4(PAR4)导致尿道上皮MIF释放,尿道上皮高迁移率族1盒(HMGB1)释放和没有膀胱炎症的小鼠的膀胱疼痛。 MIF抑制可防止所有这三种作用,而单独的膀胱内二硫化物HMGB1则可引起膀胱疼痛。这项研究利用基因MIF缺失来确定MIF是否介导PAR4诱导的膀胱疼痛,并且是否在HMGB1诱导的膀胱疼痛的上游。野生型(C57 / BL6)和MIF基因敲除(KO)小鼠用膀胱内PAR4激活肽或二硫键HMGB1处理,并在基线时(治疗前)和注射后24小时测试腹部机械性超敏反应。行为测试后检查排尿参数和膀胱组织学。实时PCR和Western印迹法测定了纯野生型膀胱中 style =“ fixed-case”> HMGB 1 m style =“ fixed-case”> RNA 和蛋白质水平和 style =“ fixed-case”> MIF KO 小鼠,而免疫荧光法检测了这两种菌株尿路上皮中的 style =“ fixed-case”> MIF KO 1蛋白水平。膀胱内 style =“ fixed-case”> PAR 4激活导致野生型小鼠腹部机械性超敏反应,但 style =“ fixed-case”> MIF KO 小鼠却没有。膀胱内二硫化物 style =“ fixed-case”> HMGB 1引起这两种菌株的腹部机械性超敏反应。两种治疗方法均未导致排尿或膀胱组织学发生明显变化。在 style =“ fixed-case”> MIF KO中, style =“ fixed-case”> HMGB 1 m style =“ fixed-case”> RNA 和蛋白质水平较高小鼠膀胱和 style =“ fixed-case”> MIF KO 膀胱的尿路上皮比野生型菌株具有更大的免疫染色。 style =“ fixed-case”> MIF 是介导 style =“ fixed-case”> PAR 4引起的膀胱疼痛并调节尿道上皮 style =“ fixed- case“> HMGB 1的产生和释放引起膀胱疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号